R.A.D. Life Sciences SRL
R.A.D. Life Sciences reported total assets of 289,261 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jan 2026).
The score of R.A.D. Life Sciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
R.A.D. Life Sciences's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,865 € | ||||
| Equity | 273,337 € | ||||
| Cash | 268,289 € | ||||
| EBITDA | 5,871 € | ||||
| Total assets | 289,261 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 08 Jan 2026
- Year ended 30 Jun 2024filed on 06 Jan 2025
- Year ended 30 Jun 2023filed on 17 Jan 2024
- Year ended 30 Jun 2022filed on 06 Feb 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
R.A.D. Life Sciences's financial analysis
- Solvency94.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of R.A.D. Life Sciences
R.A.D. Life Sciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0541.871.395
- VAT number
- BE0541871395
- Peppol
- Registered · 0208:0541871395 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Nov 2013
- Registered office
- 9840 Nazareth-De Pinte
- Latest accounts
- 2025 · filed on 08 Jan 2026
- Activity
- Activities of holding companies (NACE 64210)
R.A.D. Life Sciences (SRL) has been based in Nazareth-De Pinte since 2013, active in: activities of holding companies. For 2025, it reports a net profit of 3,865 € and equity of 273,337 €; its revenue is not published. Its solvency stands at 94.5%, above the median of its sector (55.6%).
Companies similar to R.A.D. Life Sciences
Companies in the same business, of comparable size and area, outside its group.
- CoodeR Activities of holding companies Brasschaat · balance sheet 292,388 €
- Co & Co Activities of holding companies Charleroi · balance sheet 311,968 €
- GiBo Activities of holding companies Zedelgem · balance sheet 302,705 €
- Diabasis Activities of holding companies Torhout · balance sheet 318,429 €
- North Point Activities of holding companies Floreffe · balance sheet 270,179 €
- WE-CA Activities of holding companies Raeren · balance sheet 266,552 €
- Frederic VAN Quickenborne Activities of holding companies Bruges · balance sheet 275,749 €
- Mibeno Activities of holding companies Hoogstraten · balance sheet 243,904 €
Frequently asked questions about R.A.D. Life Sciences
What is the revenue of R.A.D. Life Sciences?
R.A.D. Life Sciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of R.A.D. Life Sciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0541871395 for R.A.D. Life Sciences, if the company is VAT-registered. Its company number (CBE) is 0541.871.395.
Where is the registered office of R.A.D. Life Sciences?
According to the CBE register, the registered office of R.A.D. Life Sciences is in 9840 Nazareth-De Pinte.
What is the equity of R.A.D. Life Sciences?
At the close of the 2025 financial year, the equity of R.A.D. Life Sciences amounts to 273,337 €, a solvency of 94.5% of total assets.
Who manages R.A.D. Life Sciences?
The register lists 1 active mandates at R.A.D. Life Sciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of R.A.D. Life Sciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →